Argenx Se (ARGX) Other Operating Expenses (2016 - 2026)

Argenx Se (ARGX) posted Other Operating Expenses of $15.0 million for Q1 2026, down 58.84% on a QoQ basis from $36.4 million in Q4 2025, and down 11.76% year-over-year from $17.0 million in Q1 2025.

Argenx Se (ARGX) Other Operating Expenses (2016 - 2026) Analysis & Trends

Argenx Se's Other Operating Expenses history runs 11 years deep, the most recent figure standing at $15.0 million for Q1 2026.

  • Quarterly Other Operating Expenses fell 11.76% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.4 million (up 36.98% YoY) and the FY2025 annual result came in at $96.7 million, up 46.22% from the prior year.
  • Other Operating Expenses was $15.0 million for Q1 2026 at Argenx Se, down from $36.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $36.4 million in Q4 2025 and bottomed at $8.0 million in Q4 2022.
  • A 5-year average of $14.8 million and a median of $11.5 million in 2024 frame the typical range for Other Operating Expenses.
  • Annual changes were most pronounced in 2022 — Other Operating Expenses sank 60.47% — and 2024, when it surged 120.41%.
  • Argenx Se's Other Operating Expenses stood at $8.0 million in 2022, then jumped by 38.3% to $11.0 million in 2023, then jumped by 120.41% to $24.3 million in 2024, then jumped by 50.27% to $36.4 million in 2025, then plunged by 58.84% to $15.0 million in 2026.
  • Business Quant data shows ARGX's Other Operating Expenses at $15.0 million in Q1 2026, $36.4 million in Q4 2025, and $24.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.00 Mn
Dec 31, 2025 36.44 Mn
Sep 30, 2025 24.38 Mn
Jun 30, 2025 18.59 Mn
Mar 31, 2025 17.00 Mn
Dec 31, 2024 24.25 Mn
Sep 30, 2024 15.88 Mn
Jun 30, 2024 11.79 Mn
Mar 31, 2024 11.51 Mn
Dec 31, 2023 11.00 Mn
Sep 30, 2023 10.05 Mn
Jun 30, 2023 10.49 Mn
Mar 31, 2023 10.74 Mn
Dec 31, 2022 7.96 Mn
Sep 30, 2022 8.51 Mn
Jun 30, 2022 9.99 Mn
Mar 31, 2022 8.07 Mn
Dec 31, 2021 7.66 Mn
Sep 30, 2021 6.25 Mn
Jun 30, 2021 7.82 Mn